Pediatrix Medical Group, Inc. (MD) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Pediatrix Medical Group, Inc. (MD) Healthcare & Pipeline Overview

Pediatrix Medical Group, Inc. delivers specialized newborn, maternal-fetal, and pediatric cardiology care services throughout the U.S. and Puerto Rico. With a network of approximately 2,700 physicians as of February 2022, the company addresses critical healthcare needs for premature babies, expectant mothers, and children with congenital heart defects.

What Is the Investment Thesis for MD?

Pediatrix Medical Group presents a compelling investment case based on its established market position and specialized service offerings. With a P/E ratio of 10.9 and a profit margin of 9.0%, the company demonstrates financial stability. Growth catalysts include expanding its network of affiliated physicians and increasing demand for specialized pediatric care services. The company's beta of 0.72 suggests lower volatility compared to the broader market. However, potential risks include regulatory changes and competition within the healthcare sector. The company's focus on high-acuity care and its established presence in key markets position it for continued growth. Pediatrix's ability to maintain its gross margin of 25.8% will be crucial for sustaining profitability.

Based on FMP financials and quantitative analysis

MD Key Highlights

Market capitalization of $2.15B indicates substantial investor confidence.

• P/E ratio of 10.9 suggests the company is potentially undervalued compared to its earnings.
• Profit margin of 9.0% demonstrates effective cost management and profitability.
• Gross margin of 25.8% reflects the company's ability to generate revenue from its services.
• Beta of 0.72 indicates lower volatility compared to the overall market, making it a potentially stable investment.

Who Are MD's Competitors?

MD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MD's Key Strengths?

Established network of specialized physicians.

• Strong reputation for quality care.
• Focus on high-acuity pediatric services.
• Long-standing relationships with hospitals.

What Are MD's Weaknesses?

Reliance on third-party payers (insurance companies).

• Geographic concentration in certain regions.
• Potential for regulatory changes impacting reimbursement rates.
• Exposure to medical malpractice claims.

What Could Drive MD Stock Higher?

Expansion of telehealth services to improve access to care and increase patient volumes.

• Strategic acquisitions of smaller practices and care centers to expand geographic reach.
• Development of integrated care models to improve patient outcomes and reduce costs.
• Potential for new partnerships with hospitals to provide specialized pediatric care services.
• Implementation of data analytics initiatives to optimize resource allocation and improve clinical outcomes.

What Are the Key Risks for MD?

Changes in healthcare regulations and reimbursement policies impacting revenue.

• Increasing competition from other specialized care providers.
• Economic downturn impacting patient volumes and revenue.
• Reliance on third-party payers (insurance companies) for reimbursement.
• Exposure to medical malpractice claims.

What Are the Growth Opportunities for MD?

• Expanding Telehealth Services: Pediatrix can leverage telehealth to extend its reach to underserved areas and improve access to specialized pediatric care. The telehealth market is projected to reach $431.8 billion by 2030, offering a significant growth opportunity. By investing in telehealth infrastructure and virtual care platforms, Pediatrix can enhance patient convenience and expand its market share. This initiative can be implemented within the next 1-2 years.
• Strategic Acquisitions: Pediatrix can pursue strategic acquisitions of smaller pediatric practices and specialized care centers to expand its geographic footprint and service offerings. The market for healthcare acquisitions remains active, with numerous opportunities for consolidation. By acquiring complementary businesses, Pediatrix can enhance its market position and achieve economies of scale. These acquisitions can be targeted over the next 3-5 years.
• Developing Integrated Care Models: Pediatrix can develop integrated care models that combine neonatal, maternal-fetal, and pediatric cardiology services to provide comprehensive care for patients. Integrated care models are gaining traction as they improve patient outcomes and reduce healthcare costs. By offering a full spectrum of services, Pediatrix can attract more patients and enhance its competitive advantage. This integrated approach can be rolled out progressively over the next 2-3 years.
• Enhancing Data Analytics Capabilities: Pediatrix can invest in data analytics to improve clinical outcomes, optimize resource allocation, and identify new growth opportunities. The healthcare analytics market is expected to grow significantly in the coming years. By leveraging data analytics, Pediatrix can gain insights into patient populations, improve care delivery, and enhance operational efficiency. This initiative can be implemented within the next year.
• Expanding Partnerships with Hospitals: Pediatrix can expand its partnerships with hospitals to provide specialized pediatric care services within their facilities. Hospitals are increasingly outsourcing specialized services to improve efficiency and reduce costs. By forming strategic partnerships with hospitals, Pediatrix can expand its reach and provide high-quality care to a broader patient base. These partnerships can be developed and expanded over the next 2-5 years.

What Are MD's Competitive Advantages?

• Established network of specialized physicians and clinical professionals.
• Reputation for providing high-quality care in neonatal, maternal-fetal, and pediatric cardiology.
• Long-standing relationships with hospitals and healthcare providers.
• Specialized expertise in managing high-acuity pediatric patients.

What Does MD Do?

Founded in 1979 and based in Sunrise, Florida, Pediatrix Medical Group, Inc. has evolved into a leading provider of specialized medical care services. Initially focused on newborn care, the company expanded its offerings to include maternal-fetal medicine, pediatric cardiology, and other pediatric subspecialties. Pediatrix operates across the United States and Puerto Rico, delivering clinical care through a network of affiliated physicians and clinical professionals. The company's services encompass neonatal care for premature babies and those with complications, maternal-fetal care for expectant mothers and unborn babies, and pediatric cardiology care for children with congenital heart defects and acquired heart disease. Additionally, Pediatrix offers other pediatric subspecialty services, including pediatric intensivists, hospitalists, surgeons, and ophthalmologists. As of February 17, 2022, Pediatrix operated a network of approximately 2,700 physicians. The company provides support services within hospitals, primarily in pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Formerly known as MEDNAX, Inc., the company rebranded as Pediatrix Medical Group, Inc. in July 2022 to better reflect its focus on pediatric care.

What Products and Services Does MD Offer?

• Provides neonatal care services to premature babies and those with complications.
• Offers maternal-fetal care services to expectant mothers and unborn babies.
• Delivers pediatric cardiology care services to infants, children, and adolescents with congenital heart defects.
• Provides other pediatric subspecialty care services through pediatric intensivists, hospitalists, and surgeons.
• Offers support services in hospitals, primarily in pediatric emergency rooms and labor and delivery areas.
• Operates a network of approximately 2,700 physicians as of February 2022.
• Provides specialized cardiac care to the fetus, neonatal and pediatric patients.

How Does MD Make Money?

• Generates revenue by providing specialized medical care services to patients.
• Contracts with hospitals to provide physician staffing and management services.
• Receives payments from insurance companies and patients for services rendered.
• Expands service offerings through strategic acquisitions and partnerships.

What Industry Does MD Operate In?

Pediatrix Medical Group operates within the medical care facilities industry, which is experiencing growth due to increasing demand for specialized healthcare services. The industry is characterized by a competitive landscape, with various players offering similar services. Pediatrix differentiates itself through its focus on neonatal, maternal-fetal, and pediatric cardiology care. The aging population and advancements in medical technology are driving growth in the healthcare sector. Pediatrix's established network of physicians and its reputation for quality care position it favorably within this evolving market.

Who Are MD's Key Customers?

• Hospitals seeking specialized pediatric care services.
• Expectant mothers requiring maternal-fetal care.
• Families with premature babies or children with medical complications.
• Patients needing pediatric cardiology services.

Pediatrix Medical Group, Inc. (MD) Valuation Context

Valued at $2.15B, MD is classified as a mid-cap stock. Relative to its peer group, MD's quantitative score of 89/100 is above the peer average of 64/100.

MD Revenue & Earnings Trend

In Q2 2026, MD generated $487.8M in top-line revenue, marking a sequential increase of 2.4%. The company recorded net income of $39.8M, with diluted EPS of $0.49. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, MD averaged $0.52 in diluted EPS.

Company Profile

Pediatrix Medical Group, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Sunrise, US. The company is led by CEO Mark S. Ordan. MD has traded publicly since 1995.

Return on equity for Pediatrix Medical Group, Inc. stands at 20.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.4%, showing how much profit it generates from its asset base. MD trades at a trailing price-to-earnings ratio of 10.93, below the Healthcare sector average of ~23x. Its free cash flow yield is 11.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.0%, the inverse of the P/E and a quick read on earnings relative to price.

Pediatrix Medical Group, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.40 places it in the grey zone, a middle ground that warrants monitoring.

Pediatrix Medical Group, Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 22.6% above estimates on average.

Wall Street analysts project Pediatrix Medical Group, Inc. revenue of about $1.95B for fiscal 2026, with EPS near $2.32. The estimate reflects 5 contributing analysts.

MD Financials

MD Latest News

MD Analyst Consensus

MD MoonshotScore

Pediatrix Medical Group, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources